Eli Lilly and Company
CL ˙ SNSE ˙ US5324571083
SecurityCL:LLY / Eli Lilly and Company
InstitutionPatten & Patten Inc/tn
Latest Disclosed Ownership15,238 shares
Latest Disclosed Value $ 14,015,455
Patten & Patten Inc/tn reports 0.82% decrease in ownership of LLY / Eli Lilly and Company

On May 1, 2026 - Patten & Patten Inc/tn filed a 13F-HR form disclosing ownership of 15,238 shares of Eli Lilly and Company (CL:LLY) valued at $14,015,455 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 15,364 shares of Eli Lilly and Company. This represents a change in shares of -0.82% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F ELI LILLY COM 532457108 15,238 -126 -0.82 14,015 -15.12 0.8460
2026-02-03 2025-12-31 13F ELI LILLY COM 532457108 15,364 -912 -5.60 16,511 32.96 0.9692
2025-10-31 2025-09-30 13F ELI LILLY COM 532457108 16,276 -456 -2.73 12,419 -4.79 0.7298
2025-07-28 2025-06-30 13F ELI LILLY COM 532457108 16,732 -187 -1.11 13,043 -6.66 0.8440
2025-05-07 2025-03-31 13F ELI LILLY COM 532457108 16,919 644 3.96 13,974 11.21 0.9355
2025-02-10 2024-12-31 13F ELI LILLY COM 532457108 16,275 5 0.03 12,564 -12.83 0.8300
2024-11-04 2024-09-30 13F ELI LILLY COM 532457108 16,270 -158 -0.96 14,414 -3.09 0.9566
2024-08-13 2024-06-30 13F ELI LILLY COM 532457108 16,428 -258 -1.55 14,874 14.58 1.0400
2024-05-10 2024-03-31 13F ELI LILLY COM 532457108 16,686 1,051 6.72 12,981 42.42 0.9246
2024-01-23 2023-12-31 13F Eli Lilly COM 532457108 15,635 -1,853 -10.60 9,114 -2.97 0.7483
2023-10-27 2023-09-30 13F Eli Lilly COM 532457108 17,488 506 2.98 9,393 17.94 0.8251
2023-07-14 2023-06-30 13F Eli Lilly COM 532457108 16,982 -195 -1.14 7,964 35.03 0.6582
2023-04-25 2023-03-31 13F Eli Lilly COM 532457108 17,177 5,266 44.21 5,899 147,350.00 0.5187
2023-02-01 2022-12-31 13F Eli Lilly COM 532457108 11,911 4,631 63.61 4 -99.83 0.3956
2022-10-19 2022-09-30 13F Eli Lilly COM 532457108 7,280 151 2.12 2,354 1.82 0.2232
2022-08-02 2022-06-30 13F Eli Lilly COM 532457108 7,129 774 12.18 2,312 27.03 0.2030
2022-04-25 2022-03-31 13F Eli Lilly COM 532457108 6,355 -10 -0.16 1,820 3.53 0.1328
2022-01-26 2021-12-31 13F Eli Lilly COM 532457108 6,365 59 0.94 1,758 20.66 0.1215
2021-10-22 2021-09-30 13F Eli Lilly COM 532457108 6,306 9 0.14 1,457 0.83 0.1108
2021-07-13 2021-06-30 13F Eli Lilly COM 532457108 6,297 1,042 19.83 1,445 47.15 0.1101
2021-04-23 2021-03-31 13F Eli Lilly COM 532457108 5,255 -1,143 -17.86 982 -9.07 0.0803
2021-01-19 2020-12-31 13F Eli Lilly COM 532457108 6,398 350 5.79 1,080 20.67 0.0941
2020-10-08 2020-09-30 13F Eli Lilly COM 532457108 6,048 -164 -2.64 895 -12.25 0.0892
2020-07-21 2020-06-30 13F Eli Lilly COM 532457108 6,212 622 11.13 1,020 31.61 0.1116
2020-04-16 2020-03-31 13F Eli Lilly COM 532457108 5,590 0 0.00 775 5.44 0.1022
2020-01-13 2019-12-31 13F Eli Lilly COM 532457108 5,590 0 0.00 735 17.60 0.0739
2019-10-15 2019-09-30 13F Eli Lilly COM 532457108 5,590 351 6.70 625 7.76 0.0683
2019-07-11 2019-06-30 13F Eli Lilly COM 532457108 5,239 -50 -0.95 580 -15.45 0.0628
2019-04-23 2019-03-31 13F Eli Lilly COM 532457108 5,289 1 0.02 686 12.09 0.0752
2019-01-17 2018-12-31 13F Eli Lilly COM 532457108 5,288 0 0.00 612 7.94 0.0751
2018-10-17 2018-09-30 13F Eli Lilly COM 532457108 5,288 -60 -1.12 567 24.34 0.0561
2018-07-18 2018-06-30 13F Eli Lilly COM 532457108 5,348 -1,500 -21.90 456 -13.96 0.0468
2018-04-20 2018-03-31 13F Eli Lilly COM 532457108 6,848 -450 -6.17 530 -13.96 0.0542
2018-01-22 2017-12-31 13F Eli Lilly COM 532457108 7,298 0 0.00 616 -1.28 0.0616
2017-10-12 2017-09-30 13F Eli Lilly COM 532457108 7,298 -131 -1.76 624 2.13 0.0657
2017-07-19 2017-06-30 13F Eli Lilly COM 532457108 7,429 400 5.69 611 3.38 0.0676
2017-04-19 2017-03-31 13F Eli Lilly COM 532457108 7,029 -810 -10.33 591 2.43 0.0681
2017-01-27 2016-12-31 13F Eli Lilly COM 532457108 7,839 -299 -3.67 577 -11.64 0.0710
2016-10-12 2016-09-30 13F Eli Lilly COM 532457108 8,138 -901 -9.97 653 -8.29 0.0841
2016-07-07 2016-06-30 13F Eli Lilly COM 532457108 9,039 630 7.49 712 17.49 0.0985
2016-04-15 2016-03-31 13F Eli Lilly COM 532457108 8,409 -1,000 -10.63 606 -23.58 0.0866
2016-02-29 2015-12-31 13F Eli Lilly COM 532457108 9,409 90 0.97 793 1.67 0.1096
2015-10-22 2015-09-30 13F Eli Lilly COM 532457108 9,319 150 1.64 780 1.83 0.1190
2015-08-31 2015-06-30 13F Eli Lilly COM 532457108 9,169 -918 -9.10 766 4.50 0.1112
2015-04-16 2015-03-31 13F Eli Lilly COM 532457108 10,087 -264 -2.55 733 2.66 0.1054
2015-01-21 2014-12-31 13F Eli Lilly COM 532457108 10,351 7 0.07 714 6.41 0.1079
2014-10-14 2014-09-30 13F Eli Lilly COM 532457108 10,344 902 9.55 671 14.31 0.1068
2014-07-25 2014-06-30 13F Eli Lilly COM 532457108 9,442 -4,752 -33.48 587 -29.70 0.0954
2014-04-24 2014-03-31 13F Eli Lilly COM 532457108 14,194 8 0.06 835 15.49 0.1130
2014-01-15 2013-12-31 13F Eli Lilly COM 532457108 14,186 -1,666 -10.51 723 -9.40 0.1008
2013-10-15 2013-09-30 13F/A-1 Eli Lilly COM 532457108 15,852 -4,910 -23.65 798 -21.76 0.1238
2013-10-15 2013-09-30 13F Eli Lilly COM 532457108 20,762 1,020
2013-07-12 2013-06-30 13F Eli Lilly COM 532457108 20,762 20,762 1,020 0.1671
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.